nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Benazepril—Ramipril—type 1 diabetes mellitus	0.417	1	CrCrCtD
Imipramine—CHRM2—type 1 diabetes mellitus	0.37	1	CbGaD
Imipramine—HTR7—umbilical artery—type 1 diabetes mellitus	0.00875	0.178	CbGeAlD
Imipramine—HTR2A—arteriole—type 1 diabetes mellitus	0.00313	0.0637	CbGeAlD
Imipramine—ORM1—saliva—type 1 diabetes mellitus	0.00291	0.0591	CbGeAlD
Imipramine—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.00226	0.0418	CcSEcCtD
Imipramine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00223	0.0454	CbGeAlD
Imipramine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00218	0.0404	CcSEcCtD
Imipramine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00215	0.0438	CbGeAlD
Imipramine—Digestion impaired—Ramipril—type 1 diabetes mellitus	0.00189	0.0351	CcSEcCtD
Imipramine—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00187	0.0347	CcSEcCtD
Imipramine—SLC6A3—nerve—type 1 diabetes mellitus	0.00156	0.0317	CbGeAlD
Imipramine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00155	0.0316	CbGeAlD
Imipramine—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00153	0.0283	CcSEcCtD
Imipramine—KCND3—islet of Langerhans—type 1 diabetes mellitus	0.00148	0.0301	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00134	0.0273	CbGeAlD
Imipramine—SLC6A2—nerve—type 1 diabetes mellitus	0.00126	0.0255	CbGeAlD
Imipramine—KCND2—cardiovascular system—type 1 diabetes mellitus	0.00123	0.025	CbGeAlD
Imipramine—HTR7—nerve—type 1 diabetes mellitus	0.00121	0.0246	CbGeAlD
Imipramine—DRD2—nerve—type 1 diabetes mellitus	0.00114	0.0233	CbGeAlD
Imipramine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00113	0.021	CcSEcCtD
Imipramine—KCND3—cardiovascular system—type 1 diabetes mellitus	0.00107	0.0218	CbGeAlD
Imipramine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00106	0.0197	CcSEcCtD
Imipramine—KCND3—pancreas—type 1 diabetes mellitus	0.00104	0.0212	CbGeAlD
Imipramine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00103	0.019	CcSEcCtD
Imipramine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00099	0.0184	CcSEcCtD
Imipramine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.000969	0.0197	CbGeAlD
Imipramine—Purpura—Ramipril—type 1 diabetes mellitus	0.000952	0.0177	CcSEcCtD
Imipramine—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000941	0.0174	CcSEcCtD
Imipramine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000937	0.0174	CcSEcCtD
Imipramine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.000911	0.0169	CcSEcCtD
Imipramine—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.000878	0.0178	CbGeAlD
Imipramine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000848	0.0157	CcSEcCtD
Imipramine—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.000847	0.0172	CbGeAlD
Imipramine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000838	0.0155	CcSEcCtD
Imipramine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00083	0.0154	CcSEcCtD
Imipramine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000786	0.0146	CcSEcCtD
Imipramine—HTR2A—nerve—type 1 diabetes mellitus	0.000755	0.0153	CbGeAlD
Imipramine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000754	0.014	CcSEcCtD
Imipramine—SLC22A2—kidney—type 1 diabetes mellitus	0.000744	0.0151	CbGeAlD
Imipramine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000731	0.0136	CcSEcCtD
Imipramine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000724	0.0134	CcSEcCtD
Imipramine—Weight increased—Ramipril—type 1 diabetes mellitus	0.000722	0.0134	CcSEcCtD
Imipramine—ADRA1B—kidney—type 1 diabetes mellitus	0.000713	0.0145	CbGeAlD
Imipramine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000697	0.0129	CcSEcCtD
Imipramine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000693	0.0129	CcSEcCtD
Imipramine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000693	0.0129	CcSEcCtD
Imipramine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00069	0.0128	CcSEcCtD
Imipramine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00069	0.0128	CcSEcCtD
Imipramine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000669	0.0124	CcSEcCtD
Imipramine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00066	0.0122	CcSEcCtD
Imipramine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000635	0.0118	CcSEcCtD
Imipramine—SLC22A4—nephron tubule—type 1 diabetes mellitus	0.000628	0.0128	CbGeAlD
Imipramine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000592	0.011	CcSEcCtD
Imipramine—Flushing—Ramipril—type 1 diabetes mellitus	0.000589	0.0109	CcSEcCtD
Imipramine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000574	0.0106	CcSEcCtD
Imipramine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000572	0.0106	CcSEcCtD
Imipramine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000567	0.0105	CcSEcCtD
Imipramine—Alopecia—Ramipril—type 1 diabetes mellitus	0.000561	0.0104	CcSEcCtD
Imipramine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000556	0.0103	CcSEcCtD
Imipramine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000553	0.0103	CcSEcCtD
Imipramine—SLC22A4—kidney—type 1 diabetes mellitus	0.000552	0.0112	CbGeAlD
Imipramine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000547	0.0111	CbGeAlD
Imipramine—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000546	0.0111	CbGeAlD
Imipramine—Tension—Ramipril—type 1 diabetes mellitus	0.000543	0.0101	CcSEcCtD
Imipramine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000541	0.01	CcSEcCtD
Imipramine—Nervousness—Ramipril—type 1 diabetes mellitus	0.000537	0.00996	CcSEcCtD
Imipramine—SLC22A1—kidney—type 1 diabetes mellitus	0.000526	0.0107	CbGeAlD
Imipramine—Tremor—Ramipril—type 1 diabetes mellitus	0.000518	0.0096	CcSEcCtD
Imipramine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000513	0.00951	CcSEcCtD
Imipramine—Agitation—Ramipril—type 1 diabetes mellitus	0.000508	0.00942	CcSEcCtD
Imipramine—SLC22A3—kidney—type 1 diabetes mellitus	0.000503	0.0102	CbGeAlD
Imipramine—Malaise—Ramipril—type 1 diabetes mellitus	0.000499	0.00924	CcSEcCtD
Imipramine—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000498	0.0101	CbGeAlD
Imipramine—Syncope—Ramipril—type 1 diabetes mellitus	0.000496	0.00919	CcSEcCtD
Imipramine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000495	0.00918	CcSEcCtD
Imipramine—Palpitations—Ramipril—type 1 diabetes mellitus	0.000489	0.00906	CcSEcCtD
Imipramine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000486	0.00901	CcSEcCtD
Imipramine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000479	0.00888	CcSEcCtD
Imipramine—DRD2—retina—type 1 diabetes mellitus	0.000474	0.00964	CbGeAlD
Imipramine—Anxiety—Ramipril—type 1 diabetes mellitus	0.000469	0.0087	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000467	0.00867	CcSEcCtD
Imipramine—Discomfort—Ramipril—type 1 diabetes mellitus	0.000465	0.00862	CcSEcCtD
Imipramine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00046	0.00854	CcSEcCtD
Imipramine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000455	0.00844	CcSEcCtD
Imipramine—Oedema—Ramipril—type 1 diabetes mellitus	0.000451	0.00837	CcSEcCtD
Imipramine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000451	0.00837	CcSEcCtD
Imipramine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000444	0.00902	CbGeAlD
Imipramine—Shock—Ramipril—type 1 diabetes mellitus	0.000444	0.00823	CcSEcCtD
Imipramine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000442	0.00821	CcSEcCtD
Imipramine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000442	0.00819	CcSEcCtD
Imipramine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00044	0.00817	CcSEcCtD
Imipramine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000438	0.00813	CcSEcCtD
Imipramine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000436	0.00809	CcSEcCtD
Imipramine—CHRM3—kidney—type 1 diabetes mellitus	0.000436	0.00886	CbGeAlD
Imipramine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00043	0.00798	CcSEcCtD
Imipramine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000424	0.00862	CbGeAlD
Imipramine—HTR7—kidney—type 1 diabetes mellitus	0.000415	0.00844	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000409	0.00832	CbGeAlD
Imipramine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000408	0.00757	CcSEcCtD
Imipramine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000405	0.00751	CcSEcCtD
Imipramine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000401	0.00744	CcSEcCtD
Imipramine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000397	0.00736	CcSEcCtD
Imipramine—Dimetindene—CHRM2—type 1 diabetes mellitus	0.000396	0.0812	CrCbGaD
Imipramine—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000395	0.00803	CbGeAlD
Imipramine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000392	0.00727	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00039	0.00722	CcSEcCtD
Imipramine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000389	0.00721	CcSEcCtD
Imipramine—Constipation—Ramipril—type 1 diabetes mellitus	0.000386	0.00715	CcSEcCtD
Imipramine—Cyamemazine—CHRM2—type 1 diabetes mellitus	0.000385	0.079	CrCbGaD
Imipramine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000372	0.00689	CcSEcCtD
Imipramine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000369	0.00684	CcSEcCtD
Imipramine—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.000361	0.00734	CbGeAlD
Imipramine—Benazepril—ACE—type 1 diabetes mellitus	0.00036	0.0738	CrCbGaD
Imipramine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000358	0.00665	CcSEcCtD
Imipramine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000357	0.00661	CcSEcCtD
Imipramine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000357	0.00661	CcSEcCtD
Imipramine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000344	0.00699	CbGeAlD
Imipramine—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.000339	0.00689	CbGeAlD
Imipramine—Mequitazine—CHRM2—type 1 diabetes mellitus	0.000335	0.0686	CrCbGaD
Imipramine—Ethopropazine—CHRM2—type 1 diabetes mellitus	0.000326	0.0669	CrCbGaD
Imipramine—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.000324	0.00659	CbGeAlD
Imipramine—Asthenia—Ramipril—type 1 diabetes mellitus	0.000324	0.006	CcSEcCtD
Imipramine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000319	0.00592	CcSEcCtD
Imipramine—CYP2B6—kidney—type 1 diabetes mellitus	0.000317	0.00645	CbGeAlD
Imipramine—HTR2A—retina—type 1 diabetes mellitus	0.000313	0.00636	CbGeAlD
Imipramine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000309	0.00572	CcSEcCtD
Imipramine—Maprotiline—CHRM2—type 1 diabetes mellitus	0.000306	0.0627	CrCbGaD
Imipramine—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.000304	0.00619	CbGeAlD
Imipramine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000298	0.00553	CcSEcCtD
Imipramine—CYP2E1—kidney—type 1 diabetes mellitus	0.000298	0.00605	CbGeAlD
Imipramine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000287	0.00532	CcSEcCtD
Imipramine—Rash—Ramipril—type 1 diabetes mellitus	0.000284	0.00528	CcSEcCtD
Imipramine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000284	0.00527	CcSEcCtD
Imipramine—Headache—Ramipril—type 1 diabetes mellitus	0.000283	0.00524	CcSEcCtD
Imipramine—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.000273	0.00554	CbGeAlD
Imipramine—Nausea—Ramipril—type 1 diabetes mellitus	0.000268	0.00497	CcSEcCtD
Imipramine—Triflupromazine—CHRM2—type 1 diabetes mellitus	0.000267	0.0548	CrCbGaD
Imipramine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000265	0.00538	CbGeAlD
Imipramine—HTR2A—kidney—type 1 diabetes mellitus	0.000259	0.00526	CbGeAlD
Imipramine—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.000256	0.0052	CbGeAlD
Imipramine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00024	0.00487	CbGeAlD
Imipramine—CYP3A4—kidney—type 1 diabetes mellitus	0.00024	0.00487	CbGeAlD
Imipramine—CYP2D6—kidney—type 1 diabetes mellitus	0.000236	0.00479	CbGeAlD
Imipramine—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.000227	0.0466	CrCbGaD
Imipramine—ABCB1—retina—type 1 diabetes mellitus	0.000205	0.00417	CbGeAlD
Imipramine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000193	0.00392	CbGeAlD
Imipramine—Nortriptyline—CHRM2—type 1 diabetes mellitus	0.000184	0.0377	CrCbGaD
Imipramine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000173	0.00352	CbGeAlD
Imipramine—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.00017	0.0348	CrCbGaD
Imipramine—ABCB1—kidney—type 1 diabetes mellitus	0.00017	0.00345	CbGeAlD
Imipramine—Methotrimeprazine—CHRM2—type 1 diabetes mellitus	0.000169	0.0347	CrCbGaD
Imipramine—ABCB1—pancreas—type 1 diabetes mellitus	0.000169	0.00343	CbGeAlD
Imipramine—Promethazine—CHRM2—type 1 diabetes mellitus	0.000167	0.0342	CrCbGaD
Imipramine—Doxepin—CHRM2—type 1 diabetes mellitus	0.000165	0.0338	CrCbGaD
Imipramine—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.000161	0.0329	CrCbGaD
Imipramine—Desipramine—CHRM2—type 1 diabetes mellitus	0.000151	0.031	CrCbGaD
Imipramine—Promazine—CHRM2—type 1 diabetes mellitus	0.000147	0.0301	CrCbGaD
Imipramine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000146	0.00296	CbGeAlD
Imipramine—Desipramine—ADRB1—type 1 diabetes mellitus	0.000129	0.0265	CrCbGaD
Imipramine—Chlorpromazine—CHRM2—type 1 diabetes mellitus	0.000129	0.0264	CrCbGaD
Imipramine—Amitriptyline—CHRM2—type 1 diabetes mellitus	0.000128	0.0261	CrCbGaD
Imipramine—Oxcarbazepine—ALB—type 1 diabetes mellitus	0.000112	0.023	CrCbGaD
Imipramine—Acepromazine—ALB—type 1 diabetes mellitus	8.47e-05	0.0174	CrCbGaD
Imipramine—Thioproperazine—ALB—type 1 diabetes mellitus	8.28e-05	0.017	CrCbGaD
Imipramine—Pipotiazine—ALB—type 1 diabetes mellitus	8.15e-05	0.0167	CrCbGaD
Imipramine—Clomipramine—ALB—type 1 diabetes mellitus	6.44e-05	0.0132	CrCbGaD
Imipramine—Nortriptyline—ALB—type 1 diabetes mellitus	6.29e-05	0.0129	CrCbGaD
Imipramine—Chlorpromazine—ALB—type 1 diabetes mellitus	4.42e-05	0.00906	CrCbGaD
Imipramine—Amitriptyline—ALB—type 1 diabetes mellitus	4.37e-05	0.00895	CrCbGaD
Imipramine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.53e-06	5.24e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	5.52e-06	5.23e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.51e-06	5.23e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.51e-06	5.23e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	5.51e-06	5.22e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.5e-06	5.22e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.5e-06	5.21e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.5e-06	5.21e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.48e-06	5.2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	5.48e-06	5.2e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.48e-06	5.19e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.46e-06	5.18e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.46e-06	5.17e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.45e-06	5.16e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.42e-06	5.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.41e-06	5.13e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	5.38e-06	5.1e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.37e-06	5.09e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.36e-06	5.08e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.34e-06	5.06e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	5.33e-06	5.05e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.29e-06	5.01e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.25e-06	4.98e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.25e-06	4.98e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.24e-06	4.97e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.22e-06	4.95e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.21e-06	4.93e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.19e-06	4.92e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.17e-06	4.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.16e-06	4.9e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.16e-06	4.89e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.16e-06	4.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.15e-06	4.88e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	5.15e-06	4.88e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.14e-06	4.87e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.14e-06	4.87e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.13e-06	4.87e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.13e-06	4.86e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.12e-06	4.85e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.09e-06	4.82e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.08e-06	4.81e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	5.08e-06	4.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.07e-06	4.81e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	5.07e-06	4.8e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.07e-06	4.8e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.06e-06	4.8e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.06e-06	4.8e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.06e-06	4.79e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.05e-06	4.79e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.05e-06	4.78e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.04e-06	4.78e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.02e-06	4.76e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.01e-06	4.75e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5e-06	4.74e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.98e-06	4.72e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.97e-06	4.71e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.96e-06	4.7e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.96e-06	4.7e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.95e-06	4.69e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.92e-06	4.66e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	4.89e-06	4.64e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	4.85e-06	4.6e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	4.85e-06	4.59e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.76e-06	4.51e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—INS—type 1 diabetes mellitus	4.76e-06	4.51e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	4.72e-06	4.48e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.68e-06	4.44e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.67e-06	4.43e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.67e-06	4.43e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.67e-06	4.42e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	4.67e-06	4.42e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.66e-06	4.42e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	4.66e-06	4.42e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.65e-06	4.4e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.64e-06	4.4e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.64e-06	4.4e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	4.62e-06	4.38e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.55e-06	4.31e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.52e-06	4.29e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	4.52e-06	4.28e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.49e-06	4.26e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.47e-06	4.24e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.47e-06	4.24e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.45e-06	4.22e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	4.42e-06	4.19e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.41e-06	4.18e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	4.4e-06	4.17e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.38e-06	4.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	4.36e-06	4.14e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.32e-06	4.09e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	4.29e-06	4.07e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.29e-06	4.06e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.28e-06	4.06e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.26e-06	4.04e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.26e-06	4.04e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.25e-06	4.03e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.24e-06	4.02e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.23e-06	4.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.22e-06	4e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.22e-06	4e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	4.21e-06	4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	4.21e-06	3.99e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.19e-06	3.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	4.17e-06	3.96e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.17e-06	3.95e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.16e-06	3.94e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.16e-06	3.94e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.15e-06	3.93e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.13e-06	3.91e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	4.09e-06	3.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	4.08e-06	3.87e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.07e-06	3.86e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.05e-06	3.84e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.01e-06	3.8e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	4.01e-06	3.8e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	4e-06	3.8e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	3.99e-06	3.78e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	3.98e-06	3.77e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.97e-06	3.76e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	3.96e-06	3.76e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.95e-06	3.75e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.95e-06	3.74e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.94e-06	3.74e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	3.94e-06	3.74e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.93e-06	3.73e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.93e-06	3.72e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.93e-06	3.72e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.92e-06	3.72e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.88e-06	3.68e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.88e-06	3.68e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.87e-06	3.67e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.86e-06	3.66e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.86e-06	3.66e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.85e-06	3.65e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.85e-06	3.65e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.84e-06	3.64e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.83e-06	3.63e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.81e-06	3.61e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.8e-06	3.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.79e-06	3.6e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.78e-06	3.59e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	3.75e-06	3.56e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.7e-06	3.51e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	3.68e-06	3.48e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.64e-06	3.45e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	3.63e-06	3.44e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	3.59e-06	3.4e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.59e-06	3.4e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.58e-06	3.39e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.58e-06	3.39e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.57e-06	3.38e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.57e-06	3.38e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.56e-06	3.38e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.56e-06	3.37e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.55e-06	3.36e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.52e-06	3.34e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.52e-06	3.34e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	3.52e-06	3.33e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.51e-06	3.33e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.51e-06	3.33e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.5e-06	3.32e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.49e-06	3.31e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.46e-06	3.28e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.46e-06	3.28e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.45e-06	3.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.45e-06	3.27e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.44e-06	3.26e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.44e-06	3.26e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	3.44e-06	3.26e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.42e-06	3.24e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.37e-06	3.19e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.33e-06	3.16e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.31e-06	3.14e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.29e-06	3.12e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.29e-06	3.12e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.27e-06	3.1e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.22e-06	3.06e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.09e-06	2.93e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.04e-06	2.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.03e-06	2.87e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.03e-06	2.87e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.02e-06	2.86e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.02e-06	2.86e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.99e-06	2.83e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.98e-06	2.83e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.98e-06	2.83e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.98e-06	2.82e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.97e-06	2.82e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.97e-06	2.81e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.97e-06	2.81e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.96e-06	2.81e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.96e-06	2.81e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	2.96e-06	2.8e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.95e-06	2.8e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.94e-06	2.79e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.93e-06	2.78e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.93e-06	2.78e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.93e-06	2.77e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.92e-06	2.77e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.91e-06	2.76e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.91e-06	2.76e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.91e-06	2.75e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.89e-06	2.74e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.85e-06	2.7e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.84e-06	2.69e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.8e-06	2.66e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.77e-06	2.62e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.77e-06	2.62e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	2.74e-06	2.6e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	2.74e-06	2.6e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.71e-06	2.57e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.65e-06	2.51e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.64e-06	2.5e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.63e-06	2.49e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.61e-06	2.47e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	2.59e-06	2.45e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.55e-06	2.42e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.52e-06	2.38e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.51e-06	2.38e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.51e-06	2.37e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.5e-06	2.37e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.5e-06	2.37e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.49e-06	2.36e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	2.48e-06	2.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.47e-06	2.34e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.46e-06	2.33e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.41e-06	2.29e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.33e-06	2.21e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.32e-06	2.2e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.28e-06	2.16e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.28e-06	2.16e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.27e-06	2.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.26e-06	2.14e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.24e-06	2.12e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.23e-06	2.12e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.21e-06	2.09e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.11e-06	2e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.03e-06	1.92e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.02e-06	1.91e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.93e-06	1.83e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.86e-06	1.76e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.78e-06	1.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.75e-06	1.66e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.75e-06	1.66e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.74e-06	1.65e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.74e-06	1.65e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.72e-06	1.63e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.72e-06	1.63e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.71e-06	1.62e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.63e-06	1.55e-05	CbGpPWpGaD
